The objective of this requirement is to obtain high-quality draft genome sequences for Psal and Asal isolates obtained from disease outbreaks in BC. The sequence data from this project will be used to develop new molecular diagnostic tests that are species specific and/or suitable for identification of isolates which are highly pathogenic and/or have reduced antibiotic sensitivity. Information on antimicrobial sensitivity and virulent factors will help DFO and company veterinarians make decisions with respect to the treatment and management of these diseases as well as support vaccine development.
The buyer plans to award this contract to a named supplier without competition. If your business can do this work, send a statement of capabilities to the contracting authority before December 30, 2019. If it qualifies, the buyer must open a full competition.
Get a plain-English breakdown of this tender — what they need, who can bid, how to approach it, and tips for small suppliers. Takes a couple of seconds.